CEBPA Mutation Analysis

CEBPA (CCAAT/enhancer binding protein alpha) is a transcription factor that plays an important role in regulating gene expression in a variety of cell types. Mutations in the CEBPA gene have been associated with a variety of diseases, including acute myeloid leukemia (AML).

Several different types of CEBPA mutations can occur, including point mutations and frameshift mutations. Point mutations involve a change in a single nucleotide in the DNA sequence of the CEBPA gene, while frameshift mutations involve the addition or deletion of one or more nucleotides, causing a shift in the reading frame of the gene.

CEBPA mutation analysis involves testing for the presence of these mutations in a patient's DNA sample. CEBPA mutation analysis can be an important tool in the diagnosis, prognosis, and management of certain diseases, including AML.

The test can be performed using a variety of techniques, including:

• PCR-based assays
• Sequencing
• Next-generation sequencing (NGS) technologies.

In AML, CEBPA mutations are often used as prognostic markers, as they can help predict a patient's response to treatment and overall outcome.

Sample Type Required

>>Whole Blood
Or
>>Bone Marrow

Cost of CEBPA Mutation Analysis

The cost of CEBPA Mutation Analysis near me in Delhi ranges from INR 5000 to INR 25000.